Evaluation of a Novel MET-Targeting Camelid-Derived Antibody in Head and Neck Cancer
RL Minne, NY Luo, CM Mork, MR Wopat… - Molecular …, 2024 - ACS Publications
In head and neck squamous cell carcinoma (HNSCC), the mesenchymal epithelial transition
(MET) receptor drives cancer growth, proliferation, and metastasis. MET is known to be …
(MET) receptor drives cancer growth, proliferation, and metastasis. MET is known to be …
Synthesis and Evaluation of a Novel c-Met-Targeting Cyclic Peptide as a Potential Diagnostic Agent for Colorectal Cancer
Q Chang, K Huang, L Zou, A Li, Z Ye… - Molecular …, 2024 - ACS Publications
The mesenchymal-epithelial transition factor (c-Met) is a receptor tyrosine kinase linked to
the proliferation, survival, invasion, and metastasis of several types of cancers, including …
the proliferation, survival, invasion, and metastasis of several types of cancers, including …